Announcements Trials
Browse Landscape

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Observational 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Diabetes Mellitus 3Urinary Bladder Neoplasms 2Diabetes Mellitus, Type 2 2Pancreatic Neoplasms 1Neoplasms 1Metabolic Syndrome 1Inflammation 1Hypogonadism 1

Interventions

Pioglitazone 3Surveys and Questionnaires 2Specimen Handling 2Glucose Tolerance Test 2Biopsy 2pembrolizumab 1nabiximols 1Urine Specimen Collection 1Testosterone 1Standard of Care 1Phlebotomy 1Liquid Biopsy 1Interviews as Topic 1Hypoglycemic Agents 1Gonadotropin-Releasing Hormone 1Gastrectomy 1Endoscopic Mucosal Resection 1Electrocardiography 1Eating 1DNA 1Clinical Laboratory Techniques 1Cari-D-Tect 1Blood Specimen Collection 1Becaplermin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Diabetes Mellitus × Pioglitazone × Clear all
NCT01637935 2018-03-07

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Takeda

Completed
193,099 enrolled 15 charts
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus

NCT02958956 2018-03-07

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

Takeda

Completed
236,507 enrolled 13 charts

Diabetes Mellitus, Neoplasms

NCT00743327 2012-08-06

ADT

National Institutes of Health Clinical Center (CC)

Terminated
1 enrolled

Diabetes Mellitus, Hypogonadism, Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡